Viewing Study NCT01490632

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:33 PM
Ignite Modification Date: 2025-12-31 @ 12:08 AM
Study NCT ID: NCT01490632
Status: COMPLETED
Last Update Posted: 2019-09-27
First Post: 2011-12-09
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: A Phase 2b Study of Baricitinib in Participants With Moderate to Severe Psoriasis
Sponsor: Eli Lilly and Company
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Psoriasis View
None Skin Diseases View
None Skin Diseases, Papulosquamous View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Moderate View
None Severe View
None Plaque View
None Chronic View